Large-scale pharmaceutical industry park project settled in Kunming high-tech zone

Yunnan City Investment Health Industry Investment Co., Ltd., Yunnan City Investment and Yiyi Pharmaceutical Co., Ltd. said that through the construction of Yunnan City Investment Pharmaceutical Industry Park, to help the healthy development of the pharmaceutical sector, improve the overall asset management efficiency, enrich upstream and downstream business resources, optimize the industrial structure, practice the development of a new positioning, write a new chapter of Yunnan City Investment. When completed, the project will effectively enhance Yunnan Province's medical treatment capacity to respond to major public health emergencies, and continue to provide health services to Yunnan Province and surrounding provinces and cities, while promoting the development of the Group's pharmaceutical sector has far-reaching significance.Biomedicine and large health industry is one of the eight key industries in Yunnan Province. It is reported that during the "13th Five-Year Plan" period, Yunnan Province's biomedicine and large health industry will focus on promoting the development of high-quality raw materials industry, biopharmaceutical industry, medical and health services industry, biopharmaceutical trade industry four areas of industrial development, the implementation of the "147" action plan.The "147" action plan is simply 1 biomedicine and large health industry center, 4 bases, 7 projects. In the construction of industrial parks, to build a collection area of the biopharmaceutical industry, to Kunming High-tech Zone, Yuxi High-tech Zone, Wenshan 37 Park, Chuxiong Zhuangdian Park, etc. as the focus, to support Kunming, Yuxi, Chuxiong, Wenshan, Zhaotong, Pu'er, Benna and other states and cities to build a number of biomedical health industrial parks. During the "13th Five-Year Plan" period, the growth rate of the output value of biopharmaceutical products in key parks remained above 20%, and the contribution rate to the growth of biomedicine and large health industries in the province reached more than 70%.It can be said that the landing of this large-scale pharmaceutical industry park project has positively responded to the implementation of Yunnan Province biomedicine and large health industry "147" action plan, Kunming High-tech Zone "13th Five-Year Plan" main development of biomedicine and other three major industrial development plans.It is also worth mentioning that, in addition to Yunnan City Investment Yi Pharmaceutical Co., Ltd.'s Yunnan City Investment Pharmaceutical and Health Industrial Park project, Kunming High-tech Zone concentrated on the first batch of key projects in 2020, including Kunming Hengto Real Estate Co., Ltd.'s Evergrande Linxi County project, Yunnan Bethenny Biotech Group Co., Ltd.'s "Bethenny Group Central Factory New Base", the national new industrial demonstration base of Kunming High-tech Industrial Park, The Project, Watson Biotech Park, China The completion of these projects will provide important support for industrial upgrading, economic development, urban integration and improvement of the living environment in high-tech areas. (
Pharmaceutical
Network
)